Corporate News
September 03.2026
NEWS
Corporate News
October 01.2025
Holy Young BioMedical Co., Ltd. Secures Exclusive Taiwan Distribution Rights for Kenei Pharmaceutical Co., Ltd., Bringing High-Quality Japanese Healthcare and Pharmaceutical Products to Taiwan
Holy Young Biomedical Co., Ltd. (“Holy Young”) announced that it entered into an exclusive distribution agreement for Taiwan with renowned Japanese pharmaceutical company Kenei Pharmaceutical Co., Ltd. (“Kenei”) on October 1, 2025.
Discover More
Corporate News
February 05.2025
Holy Young BioMedical Co., Ltd. Signs Partnership Agreement with Lundoch Diagnostics AB (Sweden) to Promote AI-driven Diabetes Risk Prediction IVD Products (LDcoder) in Taiwan
Holy Young Co., Ltd. (hereinafter referred to as “Holy Young”) and Lundoch Diagnostics AB (hereinafter referred to as “Lundoch”) signed a market development partnership agreement on January 16, 2025. The collaboration aims to jointly promote the development and adoption of the AI-driven in vitro diagnostic
Discover More
Corporate News
September 22.2023